Tafasitamab: First Approval

Hoy, SM

Hoy, SM (corresponding author), Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2020; 80 (16): 1731

Abstract

Tafasitamab (tafasitamab-cxix; MONJUVI(R)) is an Fc-modified (i.e. two amino acid substitutions within the Fc region, resulting in increased Fc gamma ......

Full Text Link